Loading…
The agreement is for the use of the KetoAir breathalyzer device.
Avalon GloboCare Corp. announced on July 28, 2025, that its subsidiary, Q&A Distribution, LLC, has entered into a wholesale distribution agreement with Saga Health Corporation. The agreement pertains to the use of the KetoAir breathalyzer device in Saga Health's first responder-targeted Holistic Health Reset Program.
The KetoAir breathalyzer device will be distributed through Q&A Distribution, LLC, under the terms of the agreement. This collaboration aims to enhance Saga Health's program by integrating advanced breathalyzer technology.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.